Qingzhou Luhao Sand Mine Machinery Parts Factory

Qingzhou Lu Hao sand mining machinery parts factory located in the tourist city --- industrial machinery manufacturing base in Weifang, Shandong Qingzhou, rail road transport facilities, highways cross freely, Green Bank, long-Shenzhen Expressway from my company puts in front of a bridge .
The company was founded in 1998, is the development, design, production, sales as one of the main products are: large-scale Amoy gold vessels, small-scale gold vessels, gold machinery and equipment, gold dust extraction equipment, automatic washing machine, a small gold equipment, gold concentrator, encouraging chute, agitation cycle reciprocating gold ring re-election of uninterrupted production machinery, automatic spit gold, zircon, titanium, iron extraction, production, selection of high purity, is our own invention, to design, Leading the world's advanced level and no matter the fist product. The natural restoration of ecology is in line with the national eco-friendly products, and is submitted to the National Gold Council Science and Technology Award. The gold selection machine is equipped with foreign Nielsen technology, which is improved and greatly improved the scientific and technological content. The extraction rate of sand gold above 200 mesh is 96%, and the life expectancy is increased by three times. The products are sold in China: Northeast, Xinjiang, Sichuan, Guangxi, Yunnan, etc. Our company has export rights and welcomes friends from home and abroad to visit the company.
The cutter suction dredging vessel is a river, lake and channel dredging machinery and equipment developed by our company in 2008 with the transportation and shipping group, hydropower research institute and mechanical automation institute. It is easy to operate, with large sediment discharge and strong and durable. Leading the domestic advanced level.
Company purpose:
Integrate the world's advanced technology and create world-class products. Serve customers wholeheartedly.

Larotrectinib Intermediates

Larotinib (Vitrakvi / Larotrectinib) is the first oral tyrosine kinase inhibitor approved for the treatment of NTRK gene fusion solid tumors. It is suitable for all types of solid tumors, regardless of their original location. NTRK gene fusion is a kind of chromosomal abnormality, which is formed when NTRK gene combines with another unrelated gene, and then translates and produces abnormal TRK protein.

Larotrectinib Intermediates,Larotrectinib Intermediates Cas 1218935-60-4,Intermediates Of Larotrectinib Cas 1218935-60-4,Cas1363380-51-1 Intermediates Of Larotrectinib

Jinan Guoding Pharmaceutical Co.,Ltd , https://www.jnguodingpharma.com

Posted on